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Background: The use of assisted reproductive techniques (ART) for treatment of infertility is increasing rapidly
worldwide. However, various health effects have been reported including a higher risk of congenital malformations.
Therefore, we assessed the risk of anorectal malformations (ARM) after in-vitro fertilization (IVF) and intracytoplasmic
sperm injection (ICSI).
Methods: Data of the German Network for Congenital Uro-REctal malformations (CURE-Net) were compared to
nationwide data of the German IVF register and the Federal Statistical Office (DESTATIS). Odds ratios (95%
confidence intervals) were determined to quantify associations using multivariable logistic regression accounting for
potential confounding or interaction by plurality of births.
Results: In total, 295 ARM patients born between 1997 and 2011 in Germany, who were recruited through
participating pediatric surgeries from all over Germany and the German self-help organisation SoMA, were included.
Controls were all German live-births (n = 10,069,986) born between 1997 and 2010. Overall, 30 cases (10%) and
129,982 controls (1%) were born after IVF or ICSI, which translates to an odds ratio (95% confidence interval) of 8.7
(5.9–12.6) between ART and ARM in bivariate analyses. Separate analyses showed a significantly increased risk for
ARM after IVF (OR, 10.9; 95% CI, 6.2–19.0; P < 0.0001) as well as after ICSI (OR, 7.5; 95% CI, 4.6–12.2; P < 0.0001).
Furthermore, separate analyses of patients with isolated ARM, ARM with associated anomalies and those with a
VATER/VACTERL association showed strong associations with ART (ORs 4.9, 11.9 and 7.9, respectively). After
stratification for plurality of birth, the corresponding odds ratios (95% confidence intervals) were 7.7 (4.6–12.7) for
singletons and 4.9 (2.4–10.1) for multiple births.
Conclusions: There is a strongly increased risk for ARM among children born after ART. Elevations of risk were seen
after both IVF and ICSI. Further, separate analyses of patients with isolated ARM, ARM with associated anomalies
and those with a VATER/VACTERL association showed increased risks in each group. An increased risk of ARM was
also seen among both singletons and multiple births.
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The use of assisted reproductive techniques (ART) for
treatment of infertility is increasing rapidly worldwide
[1,2]. Besides the use of medication for ovulation induc-
tion, ART include in-vitro fertilization (IVF) and intracy-
toplasmic sperm injection (ICSI). It is estimated that
worldwide over 200,000 babies are annually born after
ART [1-3]. While most babies born after ART are
healthy, previous studies also reported on health effects,
such as higher frequencies of prematurity, low birth
weights and multiple births [4-8]. The risk of a mal-
formed child after treatment is reported to be 30-40%
higher than after spontaneous conception [9]. Specific
associations have been reported for esophageal atresia,
hypospadias (second or third degree), cleft palate, septal
heart defects and the exstrophy-epispadias complex [10-
12]. A few studies have also suggested an increased risk
of anorectal malformations (ARM) [10,13-15]. ARM are
rare birth defects concerning anus and rectum with
largely unknown causes [16]. Approximately 1 in 2,500
to 1 in 3,500 new born babies are affected worldwide
[17-19]. However, recently published studies did not re-
port any information on the various types of these rare
birth defects and ART. Furthermore, previous studies
did not stratify for IVF and ICSI and only one accounted
for plurality of birth. Also, a major problem of nearly all
studies was to find a suitable population-based or
register-based control group.
The aim of the present study was to assess the associ-
ation between ART and ARM paying particular attention
to potential variation of risk by type of ARM, and pres-
ence of associated malformations. We also aimed to clar-
ify if and to what extent the increased risk might be
explained by the impact of multiple births whose fre-
quency is increased after ART. We addressed these
questions by comparing frequencies of ART between
children born with ARM and all newborn children in
Germany using data from the German Network for Con-
genital Uro-REctal malformations (CURE-Net) [20], the
population-based data from the German IVF register
(DIR) [21] and the Federal Statistical Office (DESTATIS)
[22]. Furthermore, we separately considered IVF and
ICSI to find out possible differences in potential health
effects of these procedures.
Methods
Study population
CURE-Net, initiated in 2009, is an ongoing, multicenter
population-based study to investigate environmental and
genetic risk factors, clinical implications and psycho-
social outcome for congenital uro-rectal malformations.
Cases with ARM are identified and recruited through
participating departments of pediatric surgery all over
Germany and the German self-help organisation SoMA[23]. For this analysis, we used data from patients born
between 1997 and 2011 and diagnosed with an anorectal
malformation. Personal interviews were conducted by a
physician with parents of affected children within the
first year after child-birth using a standardized question-
naire. The questionnaire contained questions about
socio-demographic factors (gender of child, age of child,
age of parents, country of origin, education/professional
situation of the parents), family history (previous abor-
tions, parental multiple pregnancies, consanguinity and
genogram), pregnancy history and birth-related factors
(gestational age, birth weight, birth position, mode of de-
livery, multiple pregnancy, diagnostic tests during preg-
nancy, treatment with ART), and lifestyle factors of the
parents (smoking, alcohol consumption, illicit drug use,
maternal body weight, preferred nutrition). The inter-
national classification of Krickenbeck [24] was used for
standardized description of diagnostic subgroups of
ARM. Associated malformations were ascertained with
means of the London Dysmorphology Database [25]. In-
formation on environmental risk factors was collected
according to the core dataset of the European surveil-
lance of congenital anomalies (EUROCAT) [26]. The
study was approved by the ethics committees of the Uni-
versities of Heidelberg and Bonn. Written informed con-
sent was obtained from the patient for publication of
this report.
Data collection was initiated in 1997 by the German
IVF register. This data included type and modality of
performed ART procedures nationwide. Since 1998, an-
nual submission of the data is mandatory for all German
medical institutions entitled to perform ART procedures.
Before 2004, data acquisition was carried out by a ques-
tionnaire. Thereafter, the software DIRpro [27] was used.
Annual reports contained information about the number
and type of ART procedures and multiple pregnancies,
but no information on parental age, maternal body
weight, or child gender.
In this study, we compared the proportion of ARM
patients born after ART registered by CURE-Net with
the reported nationwide proportion of live-born children
following IVF or ICSI born between 1997 and 2010.
According to the IVF register, 27% of all ART proce-
dures between 1997 and 2010 were IVF and 51% were
ICSI. Only a small number of parents used the com-
bined application of IVF and ICSI (1%). Information on
the exact ART type was missing in 20%. Data on the
total number of live-births stratified by singletons and
multiple births, were obtained from the DESTATIS data-
base of the Federal Statistical Office of Germany [22].
Inclusion criteria
We included patients diagnosed with ARM, including
rare forms like rectal atresia/stenosis or recto-vaginal
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ARM infants without other anomalies and ARM infants
with multiple major anomalies. VATER (vertebral, anal,
tracheo-esophageal, renal) and VACTERL (vertebral,
anal, cardiovascular, tracheo-esophageal, renal, limb)
associations were treated as a separate group.
Statistical analysis
The t-test was used to assess possible differences in ma-
ternal age at birth between ARM cases born after ART
and ARM cases born after natural conception. For calcu-
lations of other possible differences non-parametrical
measurement methods were used (Mann–Whitney U-
test, Fisher’s exact test). In case of a normal distribution,
the mean value was calculated, otherwise the median.
We compared the frequency of ART (overall and by
type of ART) between ARM patients (overall and by ab-
sence or presence of associated anomalies) and the total
population of newborns in Germany. To control for po-
tential recall and selection bias, a subgroup analysis was
performed with data from multicenter and prospectively
collected ARM patients born between 2009 and 2011.
Information of the IVF register on the exact ART type
was missing in 20% of cases. In our analysis, the cases
were allocated to the two types of ART (IVF, ICSI)
according to the distribution of these types in the total
data set. In addition, we conducted a sensitivity analysis
to assess the impact of the unknown ART types on the
risk of ARM. Moreover, separate analyses were per-
formed for singletons and multiple births. In case of
multiple births, all children were included in the ana-
lysis. Plurality of birth was taken into account due to its
well-known relationship with both ART and ARM. Due
to aggregated data of our control group, it was not pos-
sible to control for clustering of births within one
mother. But we included a product term between ART
and plurality of birth in logistic regression models to test
for potential interaction between them. Analyses were
performed by the statistics software SAS©, version 9.2
(SAS Institute Inc., Cary, N.C., USA).
Results
In total, 295 ARM cases (172 males, 123 females) born
between 1997 and 2011 were identified of whom 30
(10%) were born after ART (Table 1). Most patients had
a perineal (cutaneous) fistula (36%). 45% of patients had
an isolated ARM, the others had one or more associated
defects. The proportion of isolated ARM was lower
among ARM patients born after ART (27%) compared
to those among patients born after unassisted concep-
tion (47%) (P = 0.05). 22% of patients were diagnosed
with a VATER/VACTERL association. Median age (inter-
quartile range [IQR]) of patients at the time of data ac-
quisition was 2 (0–7) years. The majority of patientswere born between the 37th and 42nd week of gestation
(70%), and with a normal birth weight of 2,500 g to
3,999 g (66%). The gestational age and birth weight of
ARM patients born after ART was lower compared to
naturally conceived ARM patients (P = 0.002 and
P= 0.01, respectively). 90% of all ARM patients were sin-
gletons and 10% were multiple births. Four of the mul-
tiple births were monozygotic twins and ten were
dizygotic twins where the other twin(s) was (were)
healthy. The proportion of multiple births was much
higher among ARM patients born after ART (46%) than
among ARM patients born after unassisted conception
(6%) (P < 0.0001). Other characteristics were similar, with
no significant difference between ARM patients born
after ART and ARM patients born after unassisted
conception.
Information on assisted reproductive techniques in
cases and controls is presented in Tables 2, 3, 4, 5, 6.
According to the German IVF register, 1% of children
(129,982:10,069,986) were born after IVF or ICSI
(Table 2). Compared to 10% of ARM patients born after
ART, this translates to a crude odds ratio for ARM after
IVF or ICSI of 8.7 (95% CI 5.9–12.6) with a P value
<0.0001 (Table 3). Analyses with the prospectively col-
lected ARM patients (135 patients) confirmed our find-
ing (OR, 8.8; 95% CI, 5.1–15.4; P < 0.0001). Separate
analyses for patients with isolated ARM, ARM with
associated anomalies and those with a VATER/VAC-
TERL association all showed strong associations with
ART (ORs 4.9, 11.9 and 7.9, respectively). The propor-
tion of live-born multiple births was 10% in ARM cases
(30 patients) and 3% in controls (324,630 children) (OR,
3.4; 95% CI, 2.3–5.0; P < 0.0001). This proportion was
higher in patients with isolated ARM (11%) than in
patients with associated anomalies (9%) or with a
VATER/VACTERL association (9%). The corresponding
odds ratios were 3.8, 3.0 and 3.1, respectively.
Among the ARM cases, IVF was used 13 times (4%)
and ICSI 17 times (6%) (Table 4). Both procedures were
used much less frequently in the reference group of all
newborns in Germany (IVF 0.4% vs. ICSI 0.9%). There
was a significantly increased risk for ARM after IVF
(OR, 10.9; 95% CI, 6.2–19.0; P < 0.0001) as well as after
ICSI (OR, 7.5; 95% CI, 4.6–12.2; P < 0.0001). Among the
only prospectively collected ARM patients, correspond-
ing ORs were 11.0 after IVF and 7.7 after ICSI.
After stratification by plurality of birth, somewhat
weaker but still highly significant associations of ART
with ARM were seen among both singletons (OR, 7.7;
95% CI, 4.6–12.7; P < 0.0001) and multiple births (OR,
4.9; 95% CI, 2.4–10.1; P < 0.0001) (Table 5). The same
was observed with the only prospectively collected ARM
patients. There was no statistically significant interaction
by plurality (P = 0.70). Both types of ART were strongly









Perineal (cutaneous) fistula 107 (36%) 99 (37%) 8 (27%)
Recto-urethral fistula 71 (24) 63 (24%) 8 (27%)
Recto-vesical fistula 14 (5%) 10 (4%) 4 (13%)
Vestibular fistula 37 (13%) 34 (13%) 3 (10%)
Cloaca 17 (6%) 16 (6%) 1 (3%)
Anal atresia without fistula 35 (12%) 29 (11%) 6 (20%)
Anal stenosis 5 (2%) 5 (2%) 0
Recto-vaginal fistula 3 (1%) 3 (1%) 0
Others 6 (2%) 6 (2%) 0
ARM differentiation 0.05#
Isolated malformations 132 (45%) 124 (47%) 8 (27%)
Associated malformations 163 (55%) 141 (53%) 22 (73%)
Vertebral anomalies 58 (20%) 48 (18%) 10 (33%) 0.06#
Cardiovascular anomalies 70 (24%) 64 (24%) 6 (20%) 0.82#
Tracheo-esophageal fistula and/or esophageal atresia 33 (11%) 27 (10%) 6 (20%) 0.12#
Renal (kidney) anomalies 90 (31%) 76 (29%) 14 (47%) 0.06#
Limb defects 28 (10%) 25 (9%) 3 (10%) 1.00#
VATER/VACTERL association 64 (22%) 58 (22%) 6 (20%) 1.00#
Gender 0.24#
Male 172 (58%) 151 (57%) 21 (70%)
Female 123 (42%) 114 (43%) 9 (30%)
Birth plurality <0.0001#
Singletons 265 (90%) 249 (94%) 16 (53%)
Twins 26 (9%) 16 (6%) 10 (33%)
Triplets and more 4 (1%) 0 4 (13%)
Gestational age (weeks)*, median (IQR) 38 (36–40) 38 (36–40) 37 (34–38) 0.002{
Birth weight (gram)*, median (IQR) 2,990 (2,413–3,374) 3,030 (2,457–3,400) 2,702 (1,880–3,140) 0.01{
Age of patient at time of study (years), median (IQR) 2 (0–7) 2 (0–6) 2 (1–8) 0.23{
Maternal age (years), mean± SD 32± 5.3 32 ± 5.5 32 ± 4.0 0.15Δ
Maternal BMI (kg/m2)**, median (IQR) 22.6 (20.5–25.3) 22.5 (20.6–25.2) 23.0 (20.4–26.2) 0.80{
* Data was missing in one patient born after unassisted conception.
** Data was missing in two patients born after ART and ten patients born after unassisted conception.
# Calculated by the Fisher’s exact test.
{ Calculated by the Mann–Whitney U-test.
Δ Calculated by the t-test.
ART = assisted reproductive techniques, BMI = body mass index, SD = standard deviation, IQR = interquartile range.
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multiple births (Table 6).
Discussion
To assess the association between ART and anorectal
malformations, we compared data from the multicenter
population-based CURE-Net with nationwide data from
the German IVF register and the Federal Statistical
Office. We observed a strongly and significantlyincreased risk of ARM after both IVF and ICSI. Further,
separate analyses of patients with isolated ARM and
those with associated anomalies as well as with a
VATER/VACTERL association showed strongly increased
risks in each group. Furthermore, a strongly increased
risk of ARM was seen among both singletons and mul-
tiple births.
Our finding of an increased risk for ARM is in agree-
ment with three previous epidemiological studies from
Table 2 Prevalence of ART in ARM cases of CURE-Net compared to all live-births in Germany
ARM cases in CURE-Net Nationwide prevalence








1997 14 2 14.29 (1.78–42.81) 812,173 4,163 0.51 (0.50–0.53)
1998 8 2 25.00 (3.19–65.09) 785,034 8,406 1.07 (1.05–1.09)
1999 8 1 12.50 (0.32–52.65) 770,744 9,132 1.18 (1.16–1.21)
2000 9 0 0 766,999 9,111 1.19 (1.16–1.21)
2001 13 2 15.38 (1.92–45.45) 734,475 11,098 1.51 (1.48–1.54)
2002 13 3 23.08 (5.04–53.81) 719,250 12,303 1.71 (1.68–1.74)
2003 8 0 0 706,721 17,111 2.42 (2.39–2.46)
2004 16 2 12.50 (1.55–38.35) 705,622 8,376 1.19 (1.16–1.21)
2005 10 0 0 685,795 8,611 1.26 (1.23–1.28)
2006 19 1 5.26 (0.13–26.03) 672,724 8,958 1.33 (1.30–1.36)
2007 18 1 5.56 (0.14–27.29) 684,862 10,177 1.49 (1.46–1.51)
2008 24 2 8.33 (1.03–27.00) 682,514 9,913 1.45 (1.42–1.48)
2009 52 6 11.54 (4.35–23.44) 665,126 6,330 0.95 (0.93–0.98)
2010 45 5 11.11 (3.71–24.05) 677,947 6,293 0.93 (0.91–0.95)
2011 38 3 7.89 (1.66–21.38) - - -
Total 295 30 10.17 (6.97–14.20) 10,069,986 129,982 1.29 (1.28–1.30)
ART = assisted reproductive techniques, IVF = in-vitro fertilization, ICSI = intracytoplasmic sperm injection, CI = confidence interval.
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significantly increased risk for ARM in general (Ericson
and Källén [13]: relative risk [RR], 3.1; 95% CI, 1.3–6.1;
Källén et al. [14]: OR, 4.7; 95% CI, 3.2–6.9; Midrio et al.
[15]: OR, 13.31; 95% CI, 4.0–39.6). However, Källén
et al. [28] could not confirm their results with other
cases in a second study two years later (OR, 0.90; 95%
CI, 0.37–2.18), but analysis of the first and second data
set together showed again a highly significant association
between ART and ARM (OR, 3.11; 95% CI, 2.21–4.52;
P < 0.001). Heterogeneity across both data sets was sig-
nificant (χ2 = 43.5). One American study by Reefhuis
et al. [10] stratified ARM infants by plurality of birth
and reported an increased risk of ARM after ART for
singletons (OR, 3.4; 95% CI, 1.2–8.3), but not for mul-
tiple births (OR, 1.3; 95% CI, 0.5–3.3). Three of the five
studies mentioned above have identified their cases
through the Swedish Medical Birth Register [13,14,28].
The remaining two studies obtained their information
from the pediatric surgery unit of the University of Padua
[15] and existing birth defects surveillance systems in the
United States of America [10]. Studies were heteroge-
neous with respect to case numbers and control types.
Case numbers ranged from 28 ARM cases [15] to 533
ARM cases [14]. Control groups were register-based [13-
15,28] or from the same source populations as the case
infants [10]. Control groups consisting of nationwide data
were only available in the Swedish studies [13,14,28].
Period of data acquisition ranged from six years[10,15,28] to 19 years [14]. Our risk estimates were mostly
higher than those of previous studies, but in the light of
the overlapping confidence intervals it is unclear to what
extent these differences might reflect chance variation.
The large sample size of the present study allowed dif-
ferentiation between isolated ARM and ARM with asso-
ciated defects which is common in approximately 64%
of all ARM patients [29]. This mainly concerns anomal-
ies of the kidney (31%), heart (24%) and vertebra (20%).
To our knowledge, this study is the first study specific-
ally addressing risk of isolated ARM, ARM with multiple
anomalies and the VATER/VACTERL association. Simi-
larly strong and significant associations were found for
all three subgroups.
The previously published studies assessed the associ-
ation between ARM and ART use (IVF and ICSI) in gen-
eral [10], or between ARM and IVF [13-15,28]. However,
to show possible differences between IVF and ICSI pro-
cedures we analysed data separately. There was a highly
increased risk of ARM after both ART procedures. Nor-
mally, ICSI is used when previous IVF procedures were
unsuccessful or in case of severe male infertility [30]. Al-
though the studies by Bonduelle et al. [31] and Lie et al.
[32] did not indicate an increased risk for malformed
children born after ICSI compared to IVF, this procedure
is often considered to be risky because it is more inva-
sive than routine IVF [33].
Compared to other congenital malformations, ARM is
not likely to be specifically associated with ART. For
Table 3 Bivariate associations of ART and plurality with risk of ARM
Group Population-based
controls N (%)
All ARM cases Prospectively collected ARM cases in 2009 to 2011
N (%) ORcrude
(95% CI)
P value N (%) ORcrude
(95% CI)
P value
ART No 9,940,004 (99%) 265 (90%) 1.0 (Reference) - 121 (90%) 1.0 (Reference) -
Yes 129,982 (1%) 30 (10%) 8.7 (5.9–12.6) <0.0001 14 (10%) 8.8 (5.1–15.4) <0.0001
Plurality of birth Singletons 9,745,356 (97%) 265 (90%) 1.0 (Reference) - 123 (91%) 1.0 (Reference) -
Multiple births 324,630 (3%) 30 (10%) 3.4 (2.3–5.0) <0.0001 12 (9%) 2.9 (1.6–5.3) 0.0002








P value N (%) ORcrude
(95% CI)
P value N (%) ORcrude
(95% CI)
P value
ART No 9,940,004 (99%) 124 (94%) 1.0 (Reference) - 141 (87%) 1.0 (Reference) - 58 (91%) 1.0 (Reference) -
Yes 129,982 (1%) 8 (6%) 4.9 (2.4–10.1) <0.0001 22 (14%) 11.9 (7.6–18.7) <0.0001 6 (9%) 7.9 (3.4–18.3) <0.0001
Plurality of birth Singletons 9,745,356 (97%) 117 (89%) 1.0 (Reference) - 148 (91%) 1.0 (Reference) - 58 (91%) 1.0 (Reference) -
Multiple births 324,630 (3%) 15 (11%) 3.8 (2.2–6.6) <0.0001 15 (9%) 3.0 (1.8–5.2) <0.0001 6 (9%) 3.1 (1.3–7.2) 0.005




















Table 4 Bivariate associations of type of ART with risk of ARM
Group Population-based
controls N (%)
All ARM cases Prospectively collected ARM cases in 2009 to 2011
N (%) OR (95% CI) P value N (%) OR (95% CI) P value
ART No 9,940,004 (99%) 265 (90%) 1.0 (Reference) - 121 (90%) 1.0 (Reference) -
IVF 44,844 (0.4%) 13 (4%) 10.9 (6.2–19.0) <0.0001 6 (4%) 11.0 (4.8–25.0) <0.0001
ICSI 85,138 (0.9%) 17 (6%) 7.5 (4.6–12.2) <0.0001 8 (6%) 7.7 (3.8–15.8) <0.0001
ART = assisted reproductive techniques, OR = odds ratio, CI = confidence interval.
IVF = in-vitro fertilization, ICSI = intracytoplasmic sperm injection.
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atresia, hypospadias (second or third degree), cleft pal-
ate, septal heart defects and the exstrophy-epispadias
complex [10-12]. Our finding of an increased risk for
ARM associated with ART may be due to ART per se
and/or the infertility problems of couples who conceive
following ART [34-37]. Regarding the inheritance in
ARM families, the study by Falcone et al. [38] reported a
positive family history in 1.4% of patients with ARM. In
our data set, only one father and three siblings were
affected with ARM, also resulting in a proportion of
1.4%. The respective four cases were all naturally con-
ceived. In our cohort, there was no indication that fam-
ilies with major defects conceived via ART more often
than families without major defects. However, due to
missing data for our control group, it was not possible
to examine clustering in more detail to confirm potential
genetic pathways. Blastogenesis defects, arising in the
first four weeks of pregnancy, are also conceivable as
reason for the higher risk of ARM [39]. In addition, it is
known that maternal overweight, obesity and diabetes,
identified as risk factors for ARM in the systematic re-
view and meta-analysis by Zwink et al. [16], occur more
often in women with polycystic ovary syndrome [40-42].
This hormonal disorder is also the most common cause
of infertility due to menstrual disorders.
Plurality of birth is both more common after ART and
strongly related to ARM. However, our data clearly indi-
cate that the strong relation between ART and ARM was
not explained by plurality of birth. Strong associations
between ART and ARM were seen among both single-
tons and multiple births. Compared to previous studies,Table 5 Associations of ART with risk of ARM according to plu
Plurality of birth ART Population-based
controls N (%)
All ARM cases
N (%) OR (95% CI)
Singletons No 9,664,317 (99%) 249 (94%) 1.0 (Reference)
Yes 81,039 (1%) 16 (6%) 7.7 (4.6–12.7)
Multiple births No 275,687 (85%) 16 (53%) 1.0 (Reference)
Yes 48,943 (15%) 14 (47%) 4.9 (2.4–10.1)
ART = assisted reproductive techniques, OR = odds ratio, CI = confidence interval.our twinning rate of all ARM cases is slightly higher
[43,44]. Due to lack of pertinent information in the con-
trol group, it was not possible to analyse the risk of
monozygotic and dizygotic twins separately. The study
by Harris et al. [44] assumed that the increased risk for
twins seems to be mainly associated with monozygotic
twinning.
Our study has specific strengths and limitations.
Strengths include the large sample size of both ARM
cases and controls. With 295 ARM cases it was possible
to differentiate between ART types as well as between
isolated ARM and ARM with multiple anomalies. The
nationwide control group included more than 10 million
births between 1997 and 2010. As data of 2011 will be
only available at the end of 2012 it was not possible to
include them in the analysis. Since reporting of ART
procedures in Germany is mandatory by law, the regis-
tration of ART in Germany can be considered complete.
To avoid any delay in reporting, we chose the updated
numbers of ART published in the respective subsequent
annual report. In contrast to the worldwide increase
[1,2], proportions remained nearly the same over the
years in Germany. However, there was a decrease in the
performed procedures in 2004 because of changes in the
German health system. These comprised less insurance
eligibility of treatment of ART so that couples must pay
half of the arising costs by themselves. In addition, ser-
vices of the German health insurance company are
dependent on the age of couples and available for only
three treatment cycles. Different than in other countries,
the embryo transfer in Germany is limited to a max-
imum of three embryos per treatment cycle.rality of birth
Prospectively collected ARM cases in 2009 to 2011
P value N (%) OR (95% CI) P value
- 116 (94%) 1.0 (Reference) -
<0.0001 7 (6%) 7.2 (3.4–15.4) <0.0001
- 5 (42%) 1.0 (Reference) -
<0.0001 7 (58%) 7.9 (2.5–24.9) <0.0001
Table 6 Associations of type of ART with risk of ARM according to plurality of birth
Plurality of birth ART Population-based
controls N (%)
All ARM cases Prospectively collected ARM cases in 2009 to 2011
N (%) OR (95% CI) P value N (%) OR (95% CI) P value
Singletons No 9,664,317 (99%) 249 (94%) 1.0 (Reference) - 116 (94%) 1.0 (Reference) -
IVF 26,743 (0.3%) 7 (3%) 10.2 (4.8–21.5) <0.0001 3 (3%) 9.4 (3.0–29.4) <0.0001
ICSI 54,296 (0.6%) 9 (3%) 6.4 (3.3–12.5) <0.0001 4 (3%) 6.1 (2.3–16.6) <0.0001
Multiple births No 275,687 (85%) 16 (53%) 1.0 (Reference) - 5 (42%) 1.0 (Reference) -
IVF 18,060 (6%) 6 (20%) 5.7 (2.2–14.6) <0.0001 3 (25%) 9.2 (2.2–38.3) 0.0002
ICSI 30,883 (10%) 8 (27%) 4.5 (1.9–10.4) 0.0002 4 (33%) 7.1 (1.9–26.6) 0.0006
ART = assisted reproductive techniques, OR = odds ratio, CI = confidence interval, IVF = in-vitro fertilization, ICSI = intracytoplasmic sperm injection.
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ARM cases, recruitment cannot be considered complete.
In particular, active nationwide registration started in
only 2009 and earlier cases could only be identified and
recruited retrospectively in cooperation with hospitals
and the self-help organisation SoMA. However, major
selection bias from incomplete recruitment of cases
could have occurred only if recruitment would have var-
ied by application of ART for which we do not see obvi-
ous reasons. A selection bias might also have occurred
in case of differences in prenatal care with potential im-
pact on pregnancy termination between ART and natural
conceptions. As all parents reported on regular prenatal
control examinations an impact on the results seems un-
likely. In addition, the average number of ultrasound
examinations during pregnancy did not differ relevantly
by history of ART in our data set (ARM patients born
with ART: 15 examinations; ARM patients born without
ART: 12 examinations). Nationwide data on termination
of pregnancy and death of ARM patients during the first
days of life are not yet available. Therefore, analyses were
limited to live-births only. Possible differences in the
registration of ART due to different collecting tools used
in the CURE-Net register and the IVF register are also
unlikely.
Retrospective collection of data could also have com-
promised the validity of ART information among cases.
However, IVF and ICSI are very special procedures that
are likely to be recalled correctly. Furthermore, a sub-
group analysis with prospectively collected ARM cases
born between 2009 and 2011 confirmed our findings. As
we have no information about the nationwide propor-
tion of ARM patients born with and without ART an
overlap in ARM patients can not be excluded. However,
since ARM is a rare malformation with an incidence of
1 in 2,500 to 1 in 3,500 live-births [17-19] an influence
on the results can be neglected. Exclusion of the ARM
cases from national data did not change the result.
Finally, use of controls from a nationwide registry hin-
dered comprehensive control for potential confounding
factors. We could control, however, for plurality of birth,a key risk factor of ARM, and found a strong risk in-
crease to persist in both singletons and multiple births.
It seems unlikely that this persistent strong risk could be
explained by confounding. Nevertheless, our data do not
allow differentiating the potential impact of ART itself
or of their possible indication, such as factors associated
with maternal or paternal infertility, or characteristics of
the parents, such as maternal age [37,45], or of preced-
ing treatments, such as hormonal therapies[46].
Despite its limitations, our study provides evidence for
a strong association between ART and ARM. Further re-
search should aim to elucidate the underlying mechan-
isms and to identify possible preventive actions to limit
the frequent occurrence of ARM after application of
these techniques.
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